Theseus Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
19 Oct 2022	Form 3: Stein Steven H, Director No securities owned
13 Jun 2022	Form 3: Foresite Capital Management V, Llc, 10% owner and 4 others Holds 3,335,346 shares of Common Stock
18 May 2022	Form 3: Hayden Donald J Jr, Director No securities owned
15 Oct 2021	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other
06 Oct 2021	Form 3: Omega Fund VI, L.p., 10% owner and 5 others
06 Oct 2021	Form 3: Rock Springs Capital Management Lp, 10% owner and 2 others
06 Oct 2021	Form 3: Rivera Victor, Chief Scientific Officer Holds 388,324 shares of Common Stock
06 Oct 2021	Form 3: Shakespeare William, See Remarks Holds 388,324 shares of Common Stock
06 Oct 2021	Form 3: Dukes Iain D., Director Holds 388,324 shares of Common Stock
06 Oct 2021	Form 3: Rome Michael E, Director No securities owned
06 Oct 2021	Form 3: Kerstein David, Chief Medical Officer
06 Oct 2021	Form 3: Yi Kathy, Director
06 Oct 2021	Form 3: Dahms Bradford D., Chief Financial Officer
06 Oct 2021	Form 3: Dalgarno David, Chief Technical Officer Holds 388,324 shares of Common Stock
06 Oct 2021	Form 3: Gordon Carl L, Director
06 Oct 2021	Form 3: Orbimed Advisors Llc, Director and 2 others
06 Oct 2021	Form 3: Clackson Timothy P, Director Holds 345,930 shares of Common Stock

Comments